This analysis shows improved subjective vision changes in patients with diabetic macular edema treated with ranibizumab, suggesting effective therapy outcomes.
We determined that anti-VEGF ranibizumab treatment improved objective parameters after one year of intravitreal therapy in LS, CRT and TMV. Subjective changes in visual perception improved in all the monitored parameters after one year of treatment.
No takes yet. Share an insight, caveat, or question.
Tarková et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: